InvestorsHub Logo
Followers 37
Posts 2960
Boards Moderated 0
Alias Born 01/14/2003

Re: None

Monday, 03/30/2020 11:59:20 PM

Monday, March 30, 2020 11:59:20 PM

Post# of 425644
Amarin Corporation plc (NASDAQ:AMRN) today commented on the United States District Court for the District of Nevada’s ruling in favor of the generic companies in the company’s patent litigation against two filers of abbreviated new drug applications, or ANDAs, for Amarin’s VASCEPA® (icosapent ethyl) capsule franchise.

"capsule franchise"?

what gives there?

franchise, ok.
but why "capsule"?


why were those two words added when the sentence could have ended at "(icosapent ethyl)" with no change in understanding?

odd and unnecessary, but why?




It's the ratio, baby ... the EPA/AA ratio!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News